A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

Researchers at Boston University have discovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA (TB DNA) ...

Findings of TB DNA will require larger studies to confirm clinical relevance, says researc ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The last time The Lancet Microbe featured an Editorial on CRISPR was in November 2020, to mark that year’s Nobel Prize in Chemistry, jointly awarded to Emmanuelle Charpentier and Jennifer A Doudna for ...

Trade mission itinerary of business, government, and industry briefings across Switzerland and Germany to include site visits ...

Robot adoption is advancing rapidly, driven by declining costs, rising demand, and the integration of artificial intelligence ...

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

Evexia Diagnostics now offers 20/20 BioLabs’ OneTest™ MCED test, giving clinicians affordable, biomarker insights for ...

The MarketWatch News Department was not involved in the creation of this content. -- Milestone marks first of multiple planned diagnostic product launches on NGS roadmap -- Powered by the Archer ...

IDT announces the launch of Archer FUSIONPlex™-HT Dx and VARIANTPlex™-HT Dx in vitro diagnostic (IVD) offerings. “At IDT, we believe that precision diagnostics should be as reliable as they are ...

Milestone marks first of multiple planned diagnostic product launches on NGS roadmap Powered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro ...